NCT05292209View on ClinicalTrials.gov

RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring

PHASE2RecruitingINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

June 15, 2022

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions

Atrial Fibrillation Paroxysmal

Interventions

DRUG

Riluzole 50 MG

Riluzole 50mg tablets

Trial Locations (1)

84112-5820

RECRUITING

University of Utah, Salt Lake City

All Listed Sponsors

collaborator

Ohio State University

OTHER

lead

University of Utah

OTHER